Exhibit 5.1
| | |
| | 800 Capitol St., Suite 2400 Houston, TX 77002-2925 +1 713-651-2600 +1 713-651-2700 |
February 23, 2024
5E Advanced Materials, Inc.
9329 Mariposa Road, Suite 210
Hesperia, CA 92344
| Re: | Form S-3 Registration Statement |
Ladies and Gentlemen:
We have acted as special counsel to 5E Advanced Materials, Inc., a Delaware corporation (the “Company”), in connection with the preparation of the Company’s registration statement on Form S-3 (as amended) to be filed by the Company with the U.S. Securities and Exchange Commission (the “Commission”) on or about the date hereof (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities Act”).
The Registration Statement relates to the offer and sale by certain securityholders set forth in the prospectus contained in the Registration Statement and any supplement to the prospectus of up to 85,310,403 shares (the “Resale Shares”) of common stock, par value $0.01 per share, of the Company, consisting of (i) 66,261,621 shares of Common Stock (the “Convertible Notes Resale Shares”) which are issuable upon the conversion of amounts outstanding (including principal and accrued interest thereon) under the Company’s 4.50% senior secured convertible notes issued pursuant to a convertible note purchase agreement, dated August 11, 2022, as amended by the Amended and Restated Note Purchase Agreement, dated January 18, 2024, by and among the Company, BEP Special Situations IV LLC, Ascend Global Investment Fund SPC, for and on behalf of Strategic SP (“Ascend”), Meridian Investments Corporation, and Alter Domus (US) LLC as collateral agent, (ii) 5,365,854 shares of Common Stock (the “Ascend Resale Shares”) which were issued on January 18, 2024 to Ascend pursuant to a subscription agreement, dated December 5, 2023, by and between the Company and Ascend, and (iii) 13,682,928 shares of Common Stock (the “5ECAP Resale Shares,” and together with the Convertible Notes Resale Shares and the Ascend Resale Shares, the “Resale Shares”) which were issued on January 18, 2024 and January 29, 2024 to 5ECAP, LLC (“5ECAP”) pursuant to a subscription agreement, dated January 18, 2024, by and between the Company and 5ECAP.
This opinion letter is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K promulgated under the Securities Act.